Systematic review of measurement properties of questionnaires measuring somatization in primary care patients by Sitnikova, Kate et al.
1 
 
SYSTEMATIC REVIEW OF MEASUREMENT PROPERTIES OF QUESTIONNAIRES MEASURING 
SOMATIZATION IN PRIMARY CARE PATIENTS 
Kate Sitnikova, MSc 1*, Sandra MA Dijkstra-Kersten, MSc 1, Lidwine B Mokkink, PhD 2, Berend Terluin, 
MD, PhD 1, Harm WJ van Marwijk, MD, PhD 3, Stephanie S Leone, PhD 4, Henriëtte E van der Horst, 
MD, PhD 1, Johannes C van der Wouden, PhD1 
Email: 
Kate Sitnikova: e.sitnikova@vumc.nl 
Sandra MA Dijkstra-Kersten: s.kersten@vumc.nl 
Lidwine B Mokkink: w.mokkink@vumc.nl 
Berend Terluin: b.terluin@vumc.nl 
Harm WJ van Marwijk: harm.vanmarwijk@manchester.ac.uk 
Stephanie S Leone: sleone@trimbos.nl 
Henriëtte E van der Horst: he.vanderhorst@vumc.nl 
Johannes C van der Wouden: j.vanderwouden@vumc.nl 
 
Address: 
1 Department of General Practice and Elderly Care Medicine, Amsterdam Public Health Research 
Institute, VU University Medical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, the 
Netherlands 
2 Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, VU 
University Medical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, the Netherlands 
3 Center for Primary Care, Institute of Population Health, University of Manchester, United Kingdom 
4 Department of Public Mental Health, Trimbos Institute: Netherlands Institute of Mental Health and 
Addiction, Da Costakade 45, 3521 VS Utrecht, the Netherlands 
 
* Corresponding author  
2 
 
Abstract 
Objective: The aim of this review is to critically appraise the evidence on the measurement 
properties of self-report questionnaires measuring somatization in adult primary care patients and to 
give recommendations about which questionnaires are most useful for this purpose. 
Methods: We assessed the methodological quality of included studies using the Consensus-based 
Standards for the selection of health Measurement INstruments (COSMIN) checklist. To draw overall 
conclusions about the quality of the measurement instruments, we conducted an evidence synthesis 
using predefined criteria for good measurement properties. 
Results: We found 24 papers, investigating 9 measurement instruments. Studies on the Patient 
Health Questionnaire-15 (PHQ-15) and the Four-Dimensional Symptom Questionnaire (4DSQ) 
somatization subscale were found most frequently and covered the broadest range of measurement 
properties. These questionnaires had the best internal consistency, structural validity, construct 
validity and test-retest reliability. The PHQ-15 also had good criterion validity, whereas the 4DSQ 
somatization subscale was validated in several languages. The Bodily Distress Syndrome (BDS) 
checklist had good internal consistency and structural validity. Some evidence was found for good 
construct validity and criterion validity of the Physical Symptom Checklist (PSC-51) and good 
hypotheses testing of the Symptom Check-List  (SCL-90-R) somatization subscale. However, the three 
latter questionnaires  were only studied in a small number of studies each.  
Conclusion: Based on our findings, we recommend the use of either the PHQ-15 or 4DSQ 
somatization subscale as an outcome measure for somatization in primary care. Other 
questionnaires, such as the BDS checklist, PSC-51 and the SCL-90-R somatization subscale show 
promising results but have not yet been studied extensively in primary care.  
Keywords: Measurement properties, Primary care, Self-report questionnaire, Somatization  
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Introduction 
Somatization is defined as “a tendency to experience and communicate somatic distress and 
symptoms unaccounted for by pathological findings, to attribute them to physical illness, and to seek 
medical help for them” (1). Multiple explanatory models have been proposed for this phenomenon, 
such as somatosensory amplification, sensitization, endocrine dysregulation, dysfunctional disease 
beliefs, avoidance of physical, mental and social activity, and abnormal proprioception (2). Although 
experiencing one or several medically unexplained symptoms without a known underlying medical 
explanation is common for all people, especially in stressful situations, experiencing many medically 
unexplained symptoms from various organ systems implies somatization (3). If symptoms persist, 
patients may seek medical help. This is common for people in all health care settings, but particularly 
so in primary care (4, 5). Due to its generalist nature, primary care is the first port-of-call for people 
who are worried about such physical experiences.  
Physical symptoms in primary care can be aligned across a spectrum of the number, severity and 
functional impairment of symptoms, with having just one or a few transient symptoms at one end of 
the spectrum, and having multiple severe symptoms for a long period of time and therefore meeting 
diagnostic criteria for a somatoform disorder according to the Diagnostic and Statistical Manual of 
mental disorders 4th, (DSM-IV) (6) or 5th edition (DSM-5) (7), at the other end (8).  
Experiencing multiple physical symptoms is an imperative part of somatization, therefore we restrict 
our definition of ‘somatization’ to having multiple physical symptoms at the same time and look into 
questionnaires that quantify these symptoms as a proxy for somatization. We acknowledge the 
various possible explanatory factors and consequences that somatization can have, but do not focus 
on these in the current study.    
Discussing the presence and number of the most common physical symptoms with self-report 
questionnaires can be a valuable tool for psycho-education and shared decision-making, particularly 
in primary care, as the clinical dialogue could generate different treatment modalities, such as 
cognitive behavioural therapy (9), than would have been provided for a condition with a known 
biological cause. The sooner high levels of somatization are signalled and discussed, the sooner 
patients can learn to make sense of them and the sooner appropriate care can be provided.  As a 
result, otherwise potentially unnecessary, costly, medical procedures with possible side-effects can 
be avoided. Considering the general practitioners’ (GP) and nurse practitioners’ time-restrictions, 
self-report questionnaires can be a useful, quick, non-invasive tool to assist GPs in detecting 
symptoms of somatization directly from the patient’s point of view. Research comparing the quality 
of various available measurement instruments to measure somatization in primary care has not yet 
been done. Therefore, to date, it remains unclear which measurement instrument can be used best 
for this purpose. 
Two previous studies (10, 11) provided overviews of measurement instruments, one for common 
somatic symptoms (10) and the other for somatoform disorders (11). However, neither was 
specifically focussed on use in primary care and neither used the state-of-the-art COnsensus-based 
Standards for the selection of health Measurement Instruments (COSMIN) methodology (12, 13) for 
conducting systematic reviews on measurement instruments.  
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The aim of this review is to critically appraise the evidence on the measurement properties of 
(subscales of) self-report questionnaires measuring somatization as an outcome measure in adult 
primary care patients and to give recommendations about which questionnaires are most useful for 
this purpose. 
Methods 
This review is reported according to the Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guidelines (14).  
Literature search 
A search was performed on August 13, 2015 in PubMed/Medline, Embase, Psycinfo and Cinahl from 
inception. In all databases search terms for construct, population, measurement properties and 
setting were combined using the Boolean term ‘AND’. In PubMed a validated search filter was used 
for finding articles investigating measurement properties (15). In the other databases, adapted 
versions of this search filter were used. The adaptations were performed by a scientific information 
specialist. The full search strategies for each database can be found in Appendix A. A second updated 
search was performed on October 31, 2016 following the same procedure. Reference lists of the 
included articles and reviews found during the searches, were searched to identify additional 
relevant articles. Authors of studies were contacted in case manuscripts of the studies were not 
available online. 
Inclusion and exclusion criteria 
Inclusion criteria were: 
1. The questionnaire or subscale should aim to measure somatization defined as having multiple 
physical symptoms. 
2. The study population should be adults (age 18 and above) who are patients in primary care. 
3. The instrument of study should be developed as a paper or online self-report questionnaire. 
4. The aim of the study should be the development of a measurement instrument or the evaluation 
of one or more of its measurement properties. 
5. The study should be published as a full text original article. 
 
Exclusion criteria were: 
1. Studies in languages other than English or Dutch. 
2. Studies measuring somatization as a trait, rather than a state.  
3. Studies investigating a specific functional syndrome (e.g. fibromyalgia, irritable bowel syndrome, 
chronic pain syndrome). 
4. Questionnaires including items on somatization among other items, but without a separate 
subscore for somatization.  
Selection procedure 
The selection of articles based on titles and abstracts was independently performed by two reviewers 
(KS and SDK). Afterwards, these two reviewers separately checked whether the full text articles met 
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the inclusion criteria. In case of disagreement or doubt, a third reviewer (JW/BT) was consulted in 
order to make the decision regarding inclusion of the article. 
Data extraction 
Two reviewers (KS and SDK) independently extracted and evaluated the general characteristics of the 
measurement instruments, the characteristics of the studies, and information on generalizability and 
interpretability, using a structured form. When not enough information could be obtained from the 
included articles, original development articles were consulted. Disagreement between reviewers 
was discussed until consensus was reached. 
Assessment of the methodological quality of the included studies 
The methodological quality of the studies was assessed using the COSMIN checklist (12). The COSMIN 
checklist was developed in an international Delphi Study and can be used to evaluate the 
methodological quality of studies on measurement properties. The COSMIN checklist consists of 12 
dimensions. Nine dimensions contain standards for quality of the methodological properties 
reliability, measurement error, content validity, structural validity, hypotheses testing, cross-cultural 
validity, criterion validity and responsiveness. One dimension contains standards for studies on 
interpretability. One dimension contains general requirements for articles using item response 
theory (IRT), and one dimension contains general requirements for the generalizability of results. 
 
We used the COSMIN checklist (13) to determine which measurement properties were evaluated in a 
study. Two reviewers (KS and SK) then independently evaluated the quality of the included studies 
per measurement property, using the COSMIN checklist 4-point rating scale (12, 16) (available from 
the website www.cosmin.nl). In case of disagreement or doubt, a third reviewer (JW/LM) was 
consulted 
 
We modified the COSMIN checklist slightly by omitting the two items on the percentage and handling 
of missing data. This choice was made because it is unclear how missing data contributes to 
methodological quality and what the best way to handle missing data is, when investigating 
measurement properties. It is also possible that there are no missing data at all. Also, when no 
information on missing data is given, it does not necessarily mean that missing items were not 
handled well and a lower rating of methodological quality can be given unjustifiably.  
 
Furthermore, the cross-cultural validity dimension concerns two different aspects: 1) translation of 
the instrument, and 2) the actual cross-cultural validation analysis between two culturally different 
groups. To acknowledge these two aspects, we decided to split the dimension into two sections, i.e. 
translation score (items 4-11) and the cross-cultural validation score (items 1-3 and 12-15). For 
criterion validity, we considered validated interviews based on the Diagnostic and Statistical Manual 
of mental disorders (DSM-IV) (6) criteria for somatoform disorders to be the gold standard (e.g. the 
Schedules for Clinical Assessment in Neuropsychiatry (SCAN) (17), the Structured Clinical Interview 
for DSM-IV-TR Axis I Disorders (SCID-I) (18), and the Mini International Neuropsychiatric Interview 
(MINI) (19)). Studies using other comparison instruments were not considered to address criterion 
validity but evaluated under hypotheses testing. 
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Evaluation of the study results against criteria for good measurement properties 
The results of each study were extracted and compared to criteria for good measurement properties 
developed by Prinsen and colleagues in cooperation with the COSMIN initiative (20). We slightly 
adjusted the criteria described by Prinsen et al. for reliability and criterion validity (Appendix B). The 
adjustment was done because various studies reported other appropriate coefficients besides the 
intraclass correlation coefficient (ICC) or weighted kappa when assessing reliability, and other 
appropriate values than a correlation were used when assessing criterion validity. For reliability we 
scored a ‘+’ when ICC or weighted kappa was ≥ 0.70 and also when Pearson’s correlation coefficient 
was ≥0.80. We scored a “-“ when these criteria were not met. For criterion validity we scored a ‘+’ 
when the correlation with the gold standard was ≥0.70, but also when the area under the curve 
(AUC) was ≥ 0.70 or, in case no correlation or AUC was provided, when both sensitivity and specificity 
were ≥60%. We scored a “-“ when none of these criteria were met. 
 
Data syntheses 
For each measurement instrument, the overall levels of evidence on each measurement property 
were synthesized using the results on measurement properties from all included studies (21). The 
levels of evidence were adjusted for the  methodological quality of each study. The levels of evidence 
used are provided in Table 1. 
Table 1. Levels of evidence for the quality of the measurement properties  (21) 
Level Rating Criteria 
Strong +++ or --- Consistent findings in multiple 
studies of good methodological 
quality OR in one study of 
excellent methodological 
quality 
Moderate ++ or -- Consistent findings in multiple 
studies of fair methodological 
quality OR in one study of good 
methodological quality 
Limited + or - One study of fair 
methodological quality 
Conflicting +/- Conflicting findings 
Unknown ? Only studies of poor 
methodological quality 
+ = positive rating, ? = indeterminate rating, - = negative rating 
Results 
Included studies 
The search yielded 5318 hits in total, of which 1326 hits in PubMed, 3029 in Embase, 729 in Psycinfo 
and 234 in Cinahl. An overview of the searches and selection of articles is presented in Figure 1.  
After removing duplicates, a total of 4129 articles remained. After screening titles and abstracts, 151 
articles remained and were assessed for eligibility based on their full-texts. Twenty-one articles were 
eligible for inclusion. After screening the reference list of these 21 articles, and of several reviews 
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found in the search, three more eligible articles were identified. This resulted in a total of 24 eligible 
articles describing 52 studies on 9 different measurement instruments. When using the term ‘study’, 
we refer to the investigation of one single measurement property at a time. Various studies on 
different measurement properties may be described in a single article. 
Internal consistency was assessed in 15 studies, reliability was assessed in 3, measurement error in 1, 
structural validity in 9, hypotheses testing in 13, cross-cultural validity in 3, criterion validity in 7 and 
responsiveness in 1. Content validity was not assessed in any of the studies. 
The characteristics of the studies are provided in table 2. 
Description of the questionnaires 
Table 3 summarizes the general characteristics of the included questionnaires. Twelve studies 
assessed the somatic symptom scale of the Patient Health Questionnaire (PHQ), i.e. the Patient 
Health Questionnaire-15 (PHQ-15) (22-28), and one study assessed the brief PHQ-r (29), which is a 
Turkish version of the PHQ designed for the particular study included in this review (29). The brief 
PHQ-r consists of four subscales: somatoform disorder, depressive disorders, panic disorder and 
functioning of the patient. In our review we only looked at the somatoform disorder subscale. 
Twenty-two studies described in eight papers assessed the measurement properties of the Four-
Dimensional Symptom Questionnaire (4DSQ) somatization subscale (3, 30-36). The entire 4DSQ 
consists of 4 subscales: distress, depression, anxiety and somatization. As explained above, we 
restricted ourselves to the psychometric properties of the subscale somatization. Four studies 
assessed the Symptom Check-List-90-R (SCL-90-R) somatization subscale (37, 38). The SCL-90-R is a 
comprehensive questionnaire that aims to measure a broad range of psychological problems. It 
consists of 9 subscales: somatization, obsessive-compulsive, interpersonal sensitivity, depression, 
anxiety, anger-hostility, phobic anxiety, paranoid ideation and psychoticism. Again, we only assessed 
the subscale somatization. The other measurement instruments, i.e. the Schedule for Evaluating 
Persistent Symptoms (SEPS) (39), the Physical Symptom Checklist (PSC-51) (40), the Common Mental 
Disorders Questionnaire (CMDQ) (41), the Ghent Multidimensional Somatic Complaints Scale 
(GMSCS) (42), the Screening for Somatoform Symtptoms-2 (SOMS-2) (43) and the Bodily Distress 
Syndrome (BDS) checklist (44) were assessed in one to three studies each. The SEPS records 
medically unexplained symptoms. The PSC-51 measures somatoform disorders and is based on the 
DSM-III classification (45), which is an outdated version of the DSM criteria. The CMDQ is a diagnostic 
tool for common mental disorders and it consists of three subscales: somatoform disorder, mental 
disorder and alcohol dependence. In this review we will only look into the somatoform disorder 
subscale. The items for the somatoform disorder part are taken from the Symptom Checklist (SCL-90) 
(46)and the Whiteley index (47). The GMSCS assesses somatic complaints. The SOMS-2 , is originally 
developed in German (48, 49), but in the study included in this review, the authors investigated an 
adapted Portuguese version of the SOMS-2 and a shorter version, the R-SOMS-2. Finally, the BDS 
aims to diagnose functional disorders. Three papers on the 4DSQ were written in Dutch (34-36). All 
other articles were in English. The measurement properties of the PHQ-15, 4DSQ somatization 
subscale and SCL-90-R somatization subscale were investigated by seven, five and two different 
research teams, respectively. The measurement properties of the remaining questionnaires were 
investigated by a single research team each. 
Methodological quality of the included studies on measurement properties 
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The methodological quality of studies investigating internal consistency and criterion validity varied 
widely from poor to excellent. All studies investigating structural validity and cross-cultural validity 
were of excellent quality. Most studies investigating hypotheses testing, on the other hand, were of 
fair quality, because hypotheses were frequently not stated explicitly.  
Measurement properties of the questionnaires and evidence rating 
Internal consistency 
Table 4 provides an overview of the 15 studies that assessed internal consistency (3, 23, 24, 26, 31, 
32, 34-39, 42-44). All questionnaires except the SCL-90-R somatization subscale, SEPS and the (R)-
SOMS-2 showed good internal consistency, which was supported by strong evidence. Results for the 
SEPS and the (R)-SOMS-2 could not be evaluated due to poor quality of the studies. 
Test-retest reliability 
Table 5 provides an overview of the 3 studies in which the test-retest reliability was assessed (26, 35, 
43). The PHQ-15 and the 4DSQ somatization subscale were the most reliable questionnaires, 
although the study investigating test-retest reliability of the PHQ-15 was of good methodological 
quality, while the study investigating reliability of the 4DSQ was of fair quality. The evidence  on the 
(R)-SOMS-2 could not be interpreted due to poor quality of the study. 
Measurement error 
Only one study of poor quality, on the 4DSQ somatization subscale, investigated measurement error 
(3). The study sample consisted of 1424 participants and showed the following results: standard error 
of measurement (SEM)=2.80,  smallest detectable change (SDC)=7.76. However, the SEM was 
estimated based on the Cronbach’s alpha, which is a method of poor quality according to the 
COSMIN checklist (12), and consequently, no conclusions about the measurement error could be 
drawn.  
Structural validity 
Table 6 summarizes the results for structural validity from the 9 included studies (3, 25, 31, 33, 34, 
36, 39, 42, 44). Strong evidence was found for good structural validity of the PHQ-15, the 4DSQ 
somatization subscale and BDS checklist and for poor structural validity of the GMSCS and the SEPS.  
Hypotheses testing 
The results from the 13 studies evaluating hypotheses testing (3, 22-24, 30, 34-40, 43) are provided 
in table 7. Good construct validity was supported by moderate evidence for the PHQ-15, the 4DSQ 
somatization subscale and the SCL-90-R somatization subscale. Limited evidence supported good 
construct validity of the SEPS and the PSC-51. The (R)-SOMS-2 seemed to have poor construct validity 
due to low sensitivity, however, due to poor quality of the study, the evidence could not be 
interpreted. 
Cross-cultural validity 
Cross-cultural validity was assessed in three studies on the 4DSQ somatization subscale (31-33). 
Translation of the questionnaires was not described in these studies. The studies, however, validated 
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the questionnaire in an English (31), Polish (32) and French (33) population. Strong evidence 
supported a good validation score. In all studies, results showed that the translated versions 
conveyed the same meaning as the original Dutch version of the questionnaire, i.e. none of the items 
included in any of these questionnaires showed differential item functioning between language 
groups. Also, the same cut-off points for determining severity of somatization could be used across 
language groups. 
Criterion validity  
Table 8 summarizes results from the 7 studies investigating criterion validity (22, 26-29, 40, 41). 
Strong evidence was found for good criterion validity of the PHQ(-15) and limited evidence for good 
criterion validity of the PSC-51. The CMDQ somatoform disorder subscale seems to have poor 
criterion validity, although the evidence was limited due to fair methodological quality of the study. 
Responsiveness  
Responsiveness was evaluated in one study (3) of fair quality on the 4DSQ somatization subscale. In 
this study 86 GP patients with psychosocial problems (age 40.2 (10.0) and 66% female) completed 
the 4DSQ twice within a, relatively short, time interval of 10 days. Fifty-nine of these patients 
answered a 5-point Global Impression (GI) question. The correlation between the somatization 
change scores and the GI score was weak (r=0.30 (0.04 – 0.53)). The patients were then divided into 
2 groups: improved and not improved, and receiver operating characteristic (ROC) analyses were 
performed. The area under the curve (AUC) was 0.69, just below the cut-off of 0.70 for good 
responsiveness (50). This limited evidence therefore demonstrated poor responsiveness. 
 
Discussion 
Summary of evidence 
We identified 24 articles describing 52 studies on measurement properties of 9 self-report 
questionnaires measuring somatization in the primary care setting. The PHQ-15 and the 4DSQ 
somatization subscale were studied the most, in 13 and 22 studies respectively. The SCL-90-R 
somatization subscale was described in four studies and the remaining questionnaires were 
described in only one to three studies per measurement instrument, which weakens the level of 
evidence with which the results were interpreted.  
Based on our overview, we recommend using the PHQ-15 or 4DSQ as an outcome measure of 
somatization. The choice between the PHQ-15  and 4DSQ somatization subscale seems somewhat 
equal and can be based on practical considerations. The two measurement instruments have nearly 
the same number of items, however the PHQ-15 enquires about symptoms in the previous four 
weeks, whereas the 4DSQ has a recall period of one week. Having to recall symptoms over a longer 
period of time could cause more recall bias. However, reporting symptoms from the previous week 
only, could possibly leave out important information about symptoms that were present previously, 
but by chance were less prominent in the past week. Also, the PHQ-15 includes two items enquiring 
about symptoms linked to menstruation and sexual intercourse. The 4DSQ does not include items on 
these topics. The choice for one of the two instruments could therefore depend on the patient 
population. For instance, when using a questionnaire with female patients within their reproductive 
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age range, the PHQ-15 could provide useful information. With older patients, for instance women 
after having reached menopause, the 4DSQ could possibly be more suitable. A health care provider 
interested in screening for the DSM-IV somatoform disorder may opt for the PHQ-15, as this 
instrument has been compared against this diagnosis. On the other hand, the 4DSQ somatization 
subscale may be more suitable for Polish, French and Dutch speaking patients due to its validation 
within these population groups.  
A promising measurement instrument is the BDS checklist. Although its measurement properties 
were only investigated in two studies, strong evidence was found for good internal consistency and 
structural validity. However, more research is needed to investigate the quality of the remaining 
measurement properties. 
Based on the studies included in this review the SEPS, GMSCS and the CMDQ somatoform disorder 
subscale seem less suitable for measuring somatization in primary care, due to poor structural 
validity of the first two instruments, and poor criterion validity of the latter. However, more research 
of these measurement instruments is needed to be able to draw more solid conclusions about their 
quality. 
The remaining measurement instruments, the SCL-90-R somatization subscale, PSC-51 and the (R)-
SOMS-2 have been described in a small number of studies where only two measurement properties 
were assessed. The studies on the (R)-SOMS-2 were of poor quality, therefore, no conclusions were 
drawn about it in this review. Limited to moderate evidence supported findings of several good 
measurement properties of the SCL-90-R somatization scale and the PSC-51. Studies on the SCL-90-R 
somatization subscale in other populations (general population and various secondary care patients) 
show acceptable to good psychometric properties (51-53). So once again, more research on these 
measurement instruments in primary care is needed. A point of consideration is that the PSC-51 and 
the (R)-SOMS-2 consist of 51 and 46 (or 29 in the short version) items, respectively, and are therefore 
time-consuming . 
.  
Embedding in existing literature 
One previous review provided an overview of diagnostic measurement instruments for somatoform 
disorders (11). However, this review only focused on the assessment of somatoform disorders, which 
are at the most severe spectrum of symptoms of somatization and therefore their findings only cover 
part of the broad range of symptom severity that is encountered in primary care. Also, although 
measurement properties of the measurement instruments were mentioned, no structured, thorough 
evaluation of measurement properties was made.  
Another previous study provided an overview of self-report questionnaires for common somatic 
symptoms for use in large-scale epidemiological studies in any type of population, so not specifically 
for primary care (10). The authors recommend the use of the PHQ-15SCL-90 somatization subscale. 
However, their aim was to determine which questionnaire was most suitable for research purposes 
in large-scale studies, and not in health care practice settings. Other than investigating aspects of 
reliability and validity, the authors focussed on applicability in large-scale studies by examining low 
burden to participants, to investigators with no specific expertise in the assessment of somatization, 
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and relevance for the near future. In addition, two important measurement properties, i.e. 
measurement error and responsiveness were not taken into account in their review.  In our review 
we also found positive results for the PHQ-15 in primary care, but less so for the SCL-90-R 
somatization subscale. Instead we recommend the 4DSQ somatization subscale, along with the PHQ-
15. 
Strengths and limitations 
The most important strength of this study is that we used the COSMIN taxonomy for deciding which 
measurement properties were assessed, and that we took the methodological quality of each 
individual measurement property into account when interpreting the results of the studies, and 
drawing conclusions on the quality of the included measurement. This provided a structured 
instrument for assessing all questionnaires in a consistent way.  
We modified the COSMIN standard somewhat, by omitting the missing data items from the 4-point 
rating scale. This modification had consequences for the evidence rating of the questionnaires. 
Although all results remained in the same direction, the results were of stronger quality due to the 
modification and stronger conclusions were drawn because of this. This was especially the case for 
the measurement properties ‘internal consistency’, ‘structural validity’ and ‘criterion validity’. 
A point of consideration is our definition of the term ‘somatization’, in which we only quantified the 
multiple physical symptoms. The widely used definition by Lipowski (1) also incorporates cognitions 
and behaviour of the patients with regard to their multiple physical symptoms. However, as virtually 
no questionnaire enquires about all those aspects simultaneously, it was impossible to include 
questionnaires measuring somatization according to Lipowski’s definition. Therefore, we chose to 
focus on the measurement of experienced multiple physical symptoms which can function as a proxy 
for somatization. However, to cover the entire original definition of somatization, future studies 
could take the psychological and behavioural aspects of somatization into account as well. 
Another point of consideration is that unfortunately there is no true gold standard for somatization. 
A relatively objective measure that approaches a gold standard is a diagnosis of a somatoform 
disorder according to the DSM-IV criteria. We therefore referred to these criteria as the gold 
standard in this review as well. However, it must be noted that these diagnoses only cover the 
extreme end of the spectrum of somatization. As there is in fact no gold standard for somatization, 
the comparison with the DSM-IV criteria could be considered hypotheses testing rather than 
criterion validity. 
A third limitation is that we did not include grey literature such as dissertations and conference 
abstracts. This choice may have contributed to selection bias. Also, due to practical reasons we did 
not use indirect evidence from studies in which the measurement instruments were actually used. 
Finally, we excluded full-text articles that were written in a language other than English or Dutch. 
A final point of consideration is that we chose to limit our search to studies on questionnaires that 
were developed or studied in primary care. Questionnaires studied in other populations, such as the 
general population, community samples, students, secondary care, have therefore been excluded, as 
measurement properties of measurement instruments may be different in different populations and 
settings. However, it is possible that some questionnaires could be useful, but have not yet been 
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studied in primary care, such as the Somatic Symptom Index (SSI) (54),the SOMS-7 (55) or the 
Somatic Symptom Scale-8 (SSS-8) (56). The latter questionnaire for instance performs similarly to the 
PHQ-15 in secondary care and has less items. Also, more studies are available on the SCL-90-R 
somatization subscale in the general population, secondary care and psychiatric populations (51-53, 
57). Validation of these questionnaires in primary care may yield interesting information. 
Conclusions 
The PHQ-15 and the 4DSQ somatization subscale have been studied most in primary care and show 
the most positive results on a broad array of measurement properties. We therefore recommend the 
use of one of these two instruments for measuring somatization in primary care. The choice of a 
preferred measurement instrument can differ depending on the measurement properties that have 
priority to the user of the questionnaire. Health care providers interested in the closest 
approximation to a somatoform disorder may favour the PHQ-15, whereas health care providers 
seeking the best questionnaire for Polish, French or Dutch-speaking patients may choose the 4DSQ 
somatization subscale instead. Other questionnaires, such as the BDS checklist, SCL-90-R 
somatization subscale and PSC-51 could benefit from further study  primary care. However, the BDS 
checklist and the PSC-51 consist of a larger number of items than the PHQ-15 and 4DSQ somatization 
subscale and are therefore more time-consuming. Finally, measurement properties such as 
measurement error, content validity, cross-cultural validity and responsiveness should be studied 
further in all measurement instruments using  sound research methods. 
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